FDA
-
-
-
-
-
-
-
Merck’s LIPFENDRA® (enlicitide) is the First and Only Once-Daily Oral PCSK9 Inhibitor Approved by the U.S. FDA to Reduce LDL-C in Adults with Hypercholesterolemia
-
-
-
-
-
-
-
FDA grants breakthrough designation to EMD Serono's lupus drug enpatoran
-
-
-
-
-
-
-
The Quest to Repair What Multiple Sclerosis Takes Away
-
-
-
-
-
-
-
Gilead and Merck announce successful HIV treatment trial results
-
-
-
-
-
-
-
Merck receives EU committee approval recommendation for bladder cancer drug combo
-
-
-
-
-
-
-
Merck Completes Acquisition of Terns Pharmaceuticals, Inc.
-
-
-
-
-
-
-
UBS Reiterates Buy Rating on Merck (MRK)
-
326,103 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

